Skip to Content

Counterpoint Tactical Equity I CPIEX

Medalist Rating as of | See Counterpoint Funds Investment Hub
  • NAV / 1-Day Return 18.89  /  −0.05 %
  • Total Assets 111.0 Mil
  • Adj. Expense Ratio
    1.780%
  • Expense Ratio 1.780%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Long-Short Equity
  • Investment Style Small Blend
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield 2.11%
  • Turnover 391%

USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 12:02 AM GMT+0

Morningstar’s Analysis CPIEX

Will CPIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Counterpoint Tactical Equity I’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CPIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 8.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Spdr Sp 500 Etf Long

50.15 34.4 Mil

Jpm Ind Long 2

37.03 25.4 Mil

Jpm Ind Long 1

35.63 24.4 Mil

Fidelity Inv MM Treasury I

18.10 12.4 Mil
Cash and Equivalents

United States Treasury Bills 0%

15.26 10.5 Mil
Government

Counterpoint Quantitative Equity ETF

9.98 6.8 Mil

United States Treasury Bills 0%

7.22 5.0 Mil
Government

S&P Emini 1St Wee Jan24c 1Ef4c 4570 Index

1.22 838,338

Us Dollar Future

1.06 725,799
Cash and Equivalents

RxSight Inc

0.39 269,741
Healthcare